Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autonomic and Renal Contributions to Hypertension With Androgen Deprivation Therapy

NCT07848828 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT07848828
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07848828 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autonomic and Renal Contributions to Hypertension With Androgen Deprivation Therapy
Lead sponsor
Virginia Commonwealth University
Phase
Phase 4
Overall status
Recruiting
Start date
August 1, 2026
Completion date
July 31, 2030
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

androgen deprivation therapy, autonomic dysfunction, hypertension, prostate cancer, renal disease